For many people who smoke, quitting is not just a matter of willpower. It is a tug-of-war in the brain—between the pull of ...

The hype surrounding the psychedelic drug ibogaine reached a fever pitch in April, when President Donald Trump talked up its potential at a White House event promoting increased access to psychedelics ...

Stimulating the brain's self-control center via rTMS reduces smoking by 11 cigarettes a day, outperforming reward-suppression ...

Experts are already treating addicted people with at-home neuromodulation devices to control cravings, and the future is ...

Two new studies highlight potential breakthroughs in treating mental illness and substance use disorders: psilocybin was found to trigger lasting brain changes tied to improved well-being, and ...

Addiction hits hard. It steals lives and breaks families. Yet, many see it as a sign of weak will. What if we flip that view? Addiction is a brain disorder, not a moral slip. This piece clears up why ...

Scientists from the University of California San Francisco and Imperial College London have discovered that psilocybin, the ...

Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular ...

A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one ...

At a MAHA Institute event Monday, the Health and Human Services Secretary compared his heroin withdrawal to a family member's ...

Kratom and 7-OH may be marketed as herbal supplements, but they function like opioids — shaping how clinicians treat ...